CLOSE
eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJuYW1laWQiOiJmNmNiNjg1NS0wYWFlLTQzOWQtOWNiMS1hODg2ZTM5ZGM0OGEiLCJyb2xlIjoiQXBpVXNlciIsIm5iZiI6MTYxNDM3NjQwNSwiZXhwIjoxNjE0Mzc3NjA1LCJpYXQiOjE2MTQzNzY0MDUsImlzcyI6Imh0dHBzOi8vd3d3Lm1pbnRlcmVsbGlzb24uY29tL3Blb3BsZS90b21fc2hvbiIsImF1ZCI6Imh0dHBzOi8vd3d3Lm1pbnRlcmVsbGlzb24uY29tL3Blb3BsZS90b21fc2hvbiJ9.2SbevxrtDbg-YDOSp323sJBhV62bMWQedxQ_-RkTfO4
https://www.minterellison.com/people/tom_shon
SEARCH
MENU
Tom Shon
Partner
My extensive experience in mergers and acquisitions, capital raisings and general corporate and securities matters has seen me provide commercially focused advice to major Australian and foreign companies in connection with a broad range of corporate and commercial transactions, including acquisitions and divestitures, joint ventures, due diligence, negotiating contracts, restructurings and reorganisations.
  • +61 2 9921 4214
  • +61 401 993 626

I have advised many blue chip clients in a broad range of sectors, including financial services, manufacturing, energy and resources, mining services, logistics, pharmaceutical and biotechnology.

I’m also fluent in Korean. As the leader of MinterEllison’s Korea Desk, I regularly act for major Korean multinational corporations and State-owned entities.

Career Highlights

  • Advised POSCO on $240m IPO (relisting) of Jupiter Mines on the ASX
  • Acted as independent legal advisor to POSCO Australia on its $79.6 million direct investment in ASX-listed Pilbara Minerals plus a convertible bond facility for a further $79.6 million 
  • Advised POSCO on its A$35 million sale of interest in Integra Coal Joint Venture to Vale and subsequent 100% divestment to Glencore.
  • Advised C.H. Robinson (a US publicly listed company) on its A$300 million acquisition of A.J. Considine Proprietary Limited, which operates through its subsidiaries, the APC Logistics international freight forwarding and customs broking business in Australia and New Zealand.
  • Advised Simplify Medical Pty Limited, the Australian holding company of Simplify Medical, Inc on its capital raisings. Simplify Medical is a San Francisco Bay Area-based medical device company focused on the design, development and clinical testing of the most advanced cervical artificial disc for use in the spine.
  • Acted for Perrigo Company plc and Elan Pharma International Ltd on their US$55 million acquisition of a group of OTC brands (including the Herron range of analgesics, vitamins and supplements) from affiliates of Aspen Pharmacare
  • Advised Macquarie Radio Network Limited on its A$200m merger with Fairfax Media Limited's Fairfax Radio Network.
  • Acted for Wilmar on its A$1.75 billion acquisition of Sucrogen Limited (CSR’s sugar business) from CSR.

© 2021 MinterEllison